The USEA is sad to report that Enchantez, an 18-year-old Thoroughbred gelding (Devil’s Joy x Reunion) was euthanized today due to a broken leg. Owned and ridden by Clare Walker, Enchantez was competing in the Open Intermediate division at the Champagne Run Horse Trials at the Kentucky Horse Park in Lexington, Ky. The accident happened on the landing of a jump early on the cross-country course and Walker was uninjured in the fall.
Enchantez competed through the CCI4* with his previous owner, Lindsay Oaks, and finished 35th at the 2014 Rolex Kentucky Three-Day Event. Walker and Enchantez had been together since the spring of 2015.
The USEA sends our condolences to Walker and all of Enchantez’ connections.
The spring eventing season in the Midwest is always a toss-up due to unpredictable weather. Will it rain, will it be sunny, or will it be a snowstorm? No one knows! Mid-America Combined Training Association’s (MACTA) first cross-country schooling of the season was cancelled in March due to extremely muddy footing conditions and by the time our April dates came around, COVID-19 was in full force and we were unable to host our cross-country schooling and schooling show.
The FEI has published its Policy for Enhanced Competition Safety during the COVID-19 pandemic, aimed at assisting organizers and national federations with the safe resumption of international equestrian events in line with national and local restrictions.
The United States Eventing Association (USEA) has approved additional modifications to the qualification period for the 2020 USEA American Eventing Championships (AEC) presented by Nutrena Feeds. The AEC is scheduled to take place August 25-30, 2020 at the Kentucky Horse Park in Lexington, Kentucky, and the USEA is doing everything possible to ensure a safe and successful Championship, while also ensuring fair opportunities for all.
This article will be updated to include statements as they are released from upcoming USEA recognized events regarding actions they are taking due to the coronavirus (COVID-19).